Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.
Investigator Initiated Studies (IIS) Program supports independent investigators and institutions studying Eisai products and compounds to address medical or scientific questions in neurology and oncology.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.
Investigator Sponsored Studies (ISS) supports independent investigators conducting clinical and non-clinical research to advance knowledge of Becton Dickinson products, technologies, and therapies.